We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
The latest reproduction number (R) and growth rate of coronavirus (COVID-19).
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
A summary of what attending a review panel is like and the documents that you can submit to the Independent Review Mechanism (IRM).
Prescribing or supplying veterinary medicines including requirements for registration and inspection of premises.
This page lists all the Regulatory Policy Committee's opinions.
The CMA has today published its main concerns following an initial review into the veterinary sector.
How to show MHRA you're meeting good clinical practice (GCP) standards and what to expect from an inspection.
The Regulatory Policy Committee provides the government with external, independent scrutiny of the evidence supporting changes in law that affect businesses, charities and community groups.
A review of adverse events following the use of veterinary medicines reported each year.
Clarification for the interpretation of the new elements within the Veterinary Medicines Regulations (VMRs), as amended, relating to combating antimicrobial resistance (AMR).
Public Assessment Report (PAR) reviewing available safety data for topical steroid withdrawal reactions, which have been associated with topical corticosteroids.
How to comply with the requirements on promoting medicines to the public and to prescribers and suppliers of medicines.
Evaluations made by the Rapid Review Panel (RRP) on submitted products.
A summary for caseworkers and line managers of what attending an IRM review panel is like, including the documents you’ll need to submit.
We provide independent panels that review suitability to adopt or foster and other decisions made by adoption and fostering providers. IRM works with the Department for Education .
Independent report on the UK Fintech sector by Ron Kalifa OBE.
The findings and recommendations of the national overprescribing review led by Dr Keith Ridge, Chief Pharmaceutical Officer for England.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).